BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs6983267, VEGFA, Apoptosis, Hepatitis, Breast, Laryngoscope, Bleomycin)
Bookmark Forward

QuickView for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site (biogroup)


Body Atlas

Most Correlated Tissues

  1. Salivary gland
  2. Lymph nodes
  3. Trigeminal ganglia
  4. Eosinophil of peripheral blood
  5. Kidney cortex
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alpha-1-antitrypsin deficiency
  2. Disorder of digestive system
  3. 3-Phosphoglycerate dehydrogenase deficiency
  4. Hepatocellular dysplasia
  5. Disorder of lung
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  2. dinaciclib
  3. OTS-167
  4. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  5. ON 01910.Na
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR1225
  2. ttk
  3. STK16
  4. SMAD2
  5. CHMP2A
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. GSK cancer cell line transcript profiling
  2. L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  4. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.